Doxorubicin-loaded micelles in tumor cell-specific chemotherapy
YQ Almajidi, MM Kadhim, F Alsaikhan, AT Jalil… - Environmental …, 2023 - Elsevier
Nanomedicine is a field that combines biology and engineering to improve disease
treatment, particularly in cancer therapy. One of the promising techniques utilized in this …
treatment, particularly in cancer therapy. One of the promising techniques utilized in this …
MicroRNAs: important players in breast cancer angiogenesis and therapeutic targets
The high incidence of breast cancer (BC) is linked to metastasis, facilitated by tumor
angiogenesis. MicroRNAs (miRNAs or miRs) are small non-coding RNA molecules that …
angiogenesis. MicroRNAs (miRNAs or miRs) are small non-coding RNA molecules that …
Functional interplay between long non-coding RNAs and Breast CSCs
Breast cancer (BC) represents aggressive cancer affecting most women's lives globally.
Metastasis and recurrence are the two most common factors in a breast cancer patient's …
Metastasis and recurrence are the two most common factors in a breast cancer patient's …
Signaling pathways modulated by miRNAs in breast cancer angiogenesis and new therapeutics
MicroRNAs (miRNAs) act as oncogenes or tumor suppressors by suppressing the
expression of target genes, some of which are engaged in angiogenic signaling pathways …
expression of target genes, some of which are engaged in angiogenic signaling pathways …
Understanding cancer's defense against topoisomerase-active drugs: A comprehensive review
NK Sharma, A Bahot, G Sekar, M Bansode, K Khunteta… - Cancers, 2024 - mdpi.com
Simple Summary Increasing number of cancer patients and significant mortality among
these patients are attributed to many factors including anticancer drug resistance. Among a …
these patients are attributed to many factors including anticancer drug resistance. Among a …
Investigations on anticancer activity of Eu3+ doped hydroxyapatite nanocomposites against MCF7 and 4T1 breast cancer cell lines: A structural and luminescence …
Breast cancer remains a significant global health concern, necessitating the development of
novel therapeutic approaches. In this study, we investigate the role of Eu 3+ doped …
novel therapeutic approaches. In this study, we investigate the role of Eu 3+ doped …
The role of circRNAs in resistance to doxorubicin
M Sanati, S Ghafouri-Fard - Cell Communication and Signaling, 2024 - Springer
Doxorubicin is an anthracyline recognized as an antitumor antibiotic agent. It is widely used
in the chemotherapeutic regimens in different types of cancers. Resistance to doxorubicin is …
in the chemotherapeutic regimens in different types of cancers. Resistance to doxorubicin is …
A review on the role of miR-671 in human disorders
miR-671 is encoded by a gene on 7q36. 1 and contributes to the pathogenesis of a variety of
disorders, including diverse types of cancers, atherosclerosis, ischemic stroke, liver fibrosis …
disorders, including diverse types of cancers, atherosclerosis, ischemic stroke, liver fibrosis …
Curcumin attenuates doxorubicin-induced cardiotoxicity via suppressing oxidative Stress, preventing inflammation and apoptosis: Ultrastructural and computational …
AA Shati, RA Eid, AF El-Kott, YA Alqahtani, AS Shatoor… - Heliyon, 2024 - cell.com
Currently, doxorubicin (DOX) is one of the medications commonly used in chemotherapy to
treat different types of tumors. Nonetheless, despite being effective in multiple tumors, yet its …
treat different types of tumors. Nonetheless, despite being effective in multiple tumors, yet its …
Substance P prevents doxorubicin‑induced cardiomyocyte injury by regulating apoptosis and autophagy: In vitro and in vivo evidence
FX Chen, Q Wan, QL Li, J Fang… - Molecular medicine …, 2022 - spandidos-publications.com
The function of substance P (SP) in myocardial ischemia is well understood, but its effects on
congestive heart failure are unclear. The present study aimed to use in vitro and in vivo …
congestive heart failure are unclear. The present study aimed to use in vitro and in vivo …